UTAH MEDICAL PRODUCTS INC (UTMD)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue TTM

0 20M 40M 60M Q3 '16: 40M Q4 '16: 39.3M Q1 '17: 39.3M Q2 '17: 39.6M Q3 '17: 40.1M Q4 '17: 41.4M Q1 '18: 42M Q2 '18: 42.2M Q3 '18: 42.4M Q4 '18: 42M Q1 '19: 41.8M Q2 '19: 42.7M Q3 '19: 44.8M Q4 '19: 46.9M Q1 '20: 47.1M Q2 '20: 44M Q3 '20: 42M Q4 '20: 42.2M Q1 '21: 42.2M Q2 '21: 46.1M Q3 '21: 48.1M Q4 '21: 49.1M Q1 '22: 50.4M Q2 '22: 51.2M Q3 '22: 51.6M Q4 '22: 52.3M Q1 '23: 52.5M Q2 '23: 51.9M Q3 '23: 51.5M Q4 '23: 50.2M Q1 '24: 49M Q2 '24: 46.6M Q3 '24: 44.1M Q4 '24: 40.9M Q1 '25: 39.3M Q2 '25: 38.8M Q3 '25: 38.6M Q4 '25: 38.5M Q1 '26: 37.5M Q2 '26: 36.1M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Gross Profit TTM

0 15M 30M 45M Q3 '16: 24.1M Q4 '16: 23.7M Q1 '17: 24M Q2 '17: 24.6M Q3 '17: 25.4M Q4 '17: 26.4M Q1 '18: 26.8M Q2 '18: 26.9M Q3 '18: 26.7M Q4 '18: 26.3M Q1 '19: 26.2M Q2 '19: 26.7M Q3 '19: 27.8M Q4 '19: 29.5M Q1 '20: 29.5M Q2 '20: 27M Q3 '20: 26.1M Q4 '20: 25.5M Q1 '21: 25.7M Q2 '21: 28.5M Q3 '21: 30.1M Q4 '21: 30.9M Q1 '22: 31.5M Q2 '22: 31.9M Q3 '22: 32M Q4 '22: 32.2M Q1 '23: 32.5M Q2 '23: 32.1M Q3 '23: 31.3M Q4 '23: 30M Q1 '24: 29M Q2 '24: 27.5M Q3 '24: 25.9M Q4 '24: 24.1M Q1 '25: 22.9M Q2 '25: 22.3M Q3 '25: 22.1M Q4 '25: 22M Q1 '26: 21.7M Q2 '26: 20.9M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating Income TTM

0 7M 14M 21M Q3 '16: 16.4M Q4 '16: 16.2M Q1 '17: 16.6M Q2 '17: 17.3M Q3 '17: 18.1M Q4 '17: 19M Q1 '18: 19.3M Q2 '18: 19.3M Q3 '18: 19M Q4 '18: 18.7M Q1 '19: 17.8M Q2 '19: 17.3M Q3 '19: 17.2M Q4 '19: 17.6M Q1 '20: 17.4M Q2 '20: 14.9M Q3 '20: 14.1M Q4 '20: 13.7M Q1 '21: 13.7M Q2 '21: 16.5M Q3 '21: 18M Q4 '21: 18.9M Q1 '22: 19.5M Q2 '22: 19.8M Q3 '22: 19.9M Q4 '22: 19.8M Q1 '23: 19.7M Q2 '23: 19.1M Q3 '23: 17.9M Q4 '23: 16.8M Q1 '24: 16.2M Q2 '24: 15.2M Q3 '24: 14.6M Q4 '24: 13.6M Q1 '25: 12.9M Q2 '25: 12.6M Q3 '25: 11.9M Q4 '25: 11.4M Q1 '26: 10.8M Q2 '26: 10.3M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Net Income TTM

0 7M 14M 21M Q3 '16: 12.6M Q4 '16: 12.1M Q1 '17: 12.4M Q2 '17: 13.1M Q3 '17: 13.7M Q4 '17: 8.5M Q1 '18: 9.1M Q2 '18: 9.5M Q3 '18: 12.6M Q4 '18: 18.6M Q1 '19: 17.6M Q2 '19: 16.8M Q3 '19: 13.8M Q4 '19: 14.7M Q1 '20: 14.7M Q2 '20: 12.5M Q3 '20: 11.7M Q4 '20: 10.8M Q1 '21: 10.7M Q2 '21: 12.8M Q3 '21: 14.1M Q4 '21: 14.8M Q1 '22: 15.3M Q2 '22: 16M Q3 '22: 16M Q4 '22: 16.5M Q1 '23: 17.2M Q2 '23: 17.2M Q3 '23: 16.9M Q4 '23: 16.6M Q1 '24: 16.4M Q2 '24: 15.6M Q3 '24: 15.3M Q4 '24: 13.9M Q1 '25: 13M Q2 '25: 12.6M Q3 '25: 11.6M Q4 '25: 11.3M Q1 '26: 10.8M Q2 '26: 10.5M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Cost of Revenue TTM

0 7M 14M 21M Q2 '18: 15.3M Q3 '18: 15.8M Q4 '18: 15.7M Q1 '19: 15.7M Q2 '19: 16.1M Q3 '19: 17.1M Q4 '19: 17.4M Q1 '20: 17.5M Q2 '20: 17M Q3 '20: 15.9M Q4 '20: 16.6M Q1 '21: 16.6M Q2 '21: 17.6M Q3 '21: 18.1M Q4 '21: 18.1M Q1 '22: 18.9M Q2 '22: 19.4M Q3 '22: 19.6M Q4 '22: 20.1M Q1 '23: 20M Q2 '23: 19.8M Q3 '23: 20.2M Q4 '23: 20.2M Q1 '24: 20.1M Q2 '24: 19.1M Q3 '24: 18.2M Q4 '24: 16.8M Q1 '25: 16.4M Q2 '25: 16.6M Q3 '25: 16.6M Q4 '25: 16.5M Q1 '26: 15.8M Q2 '26: 15.2M Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating Cash Flow TTM

0 8M 16M 24M Q3 '16: 15M Q4 '16: 14.5M Q1 '17: 14.7M Q2 '17: 14.5M Q3 '17: 15.7M Q4 '17: 16.9M Q1 '18: 16.4M Q2 '18: 16.9M Q3 '18: 16.9M Q4 '18: 16.8M Q1 '19: 16.4M Q2 '19: 14.1M Q3 '19: 15.9M Q4 '19: 17.1M Q1 '20: 19.4M Q2 '20: 21.4M Q3 '20: 20M Q4 '20: 20.1M Q1 '21: 20M Q2 '21: 21M Q3 '21: 22M Q4 '21: 21.2M Q1 '22: 20.7M Q2 '22: 20.9M Q3 '22: 20.5M Q4 '22: 21.1M Q1 '23: 23M Q2 '23: 23.1M Q3 '23: 22.6M Q4 '23: 22.3M Q1 '24: 20.6M Q2 '24: 18.5M Q3 '24: 17.2M Q4 '24: 14.8M Q1 '25: 14M Q2 '25: 14.1M Q3 '25: 14.2M Q4 '25: 14.7M Q1 '26: 13.3M Q2 '26: 11.8M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Free Cash Flow TTM

0 8M 16M 24M Q3 '16: 14.8M Q4 '16: 11.2M Q1 '17: 11.4M Q2 '17: 11.2M Q3 '17: 12.5M Q4 '17: 15.3M Q1 '18: 14.7M Q2 '18: 15.2M Q3 '18: 15.3M Q4 '18: 16.4M Q1 '19: 16.2M Q2 '19: 13.8M Q3 '19: 15.5M Q4 '19: 16.5M Q1 '20: 18.4M Q2 '20: 20.2M Q3 '20: 18.9M Q4 '20: 19.3M Q1 '21: 19.6M Q2 '21: 20.6M Q3 '21: 21.6M Q4 '21: 20.7M Q1 '22: 19.9M Q2 '22: 20.1M Q3 '22: 19.4M Q4 '22: 20.3M Q1 '23: 22.4M Q2 '23: 22.4M Q3 '23: 22M Q4 '23: 21.6M Q1 '24: 20M Q2 '24: 18.1M Q3 '24: 16.9M Q4 '24: 14.6M Q1 '25: 13.6M Q2 '25: 13.8M Q3 '25: 13.9M Q4 '25: 14.3M Q1 '26: 13M Q2 '26: 11.4M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 1.5M 3M 4.5M Q2 '13: 3.8M Q3 '13: 3.8M Q1 '14: 3.8M Q2 '14: 3.8M Q3 '14: 3.8M Q1 '15: 3.8M Q2 '15: 3.8M Q3 '15: 3.8M Q1 '16: 3.8M Q2 '16: 3.8M Q3 '16: 3.8M Q1 '17: 3.7M Q2 '17: 3.7M Q3 '17: 3.7M Q1 '18: 3.7M Q2 '18: 3.8M Q3 '18: 3.8M Q1 '19: 3.7M Q2 '19: 3.7M Q3 '19: 3.7M Q1 '20: 3.7M Q2 '20: 3.7M Q3 '20: 3.7M Q1 '21: 3.7M Q2 '21: 3.7M Q3 '21: 3.7M Q1 '22: 3.7M Q2 '22: 3.6M Q3 '22: 3.6M Q1 '23: 3.6M Q2 '23: 3.6M Q3 '23: 3.6M Q1 '24: 3.6M Q2 '24: 3.5M Q3 '24: 3.5M Q1 '25: 3.3M Q2 '25: 3.2M Q3 '25: 3.2M Q1 '26: 3.2M Q2 '26: 3.2M Q3 '14 Q2 '16 Q1 '18 Q3 '19 Q2 '21 Q1 '23 Q3 '24 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 2.00 4.00 6.00 Q3 '16: 3.34 Q4 '16: 3.22 Q1 '17: 3.32 Q2 '17: 3.50 Q3 '17: 3.69 Q4 '17: 2.29 Q1 '18: 2.43 Q2 '18: 2.54 Q3 '18: 3.37 Q4 '18: 4.95 Q1 '19: 4.70 Q2 '19: 4.49 Q3 '19: 3.68 Q4 '19: 3.94 Q1 '20: 3.94 Q2 '20: 3.36 Q3 '20: 3.17 Q4 '20: 2.94 Q1 '21: 2.93 Q2 '21: 3.51 Q3 '21: 3.86 Q4 '21: 4.05 Q1 '22: 4.18 Q2 '22: 4.36 Q3 '22: 4.39 Q4 '22: 4.51 Q1 '23: 4.71 Q2 '23: 4.74 Q3 '23: 4.64 Q4 '23: 4.57 Q1 '24: 4.50 Q2 '24: 4.33 Q3 '24: 4.27 Q4 '24: 3.95 Q1 '25: 3.78 Q2 '25: 3.74 Q3 '25: 3.54 Q4 '25: 3.48 Q1 '26: 3.38 Q2 '26: 3.28 Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.